Market Data 
Markets
Replies to post #172055 on Biotech Values
01/01/14 4:56 PM
01/05/14 2:45 PM
01/14/14 1:02 PM
01/30/14 9:47 PM
The Company expects full-year revenues for 2014 to increase between 3.0% and 5.0% on a constant currency basis. The Company estimates that foreign currency translation will decrease revenues by approximately 0.5% for the full year 2014, resulting in reported revenue growth between 2.5% and 4.5%. Full-year 2014 diluted earnings per share are projected to be in a range of $5.00 to $5.20 on a reported basis [GAAP] and $6.10 to $6.30 on an adjusted basis [non-GAAP].
AI
